Medical/Pharmaceuticals
Brii Bio Presents Positive Phase 3 Data on BRII-196/BRII-198, the Company's SARS-CoV-2 Monoclonal Neutralizing Antibody Combination Therapy, in an Oral Late-Breaker Presentation at IDWeek 2021
DURHAM, N.C.and BEIJING, Oct. 4, 2021 /PRNewswire/ -- Brii Biosciences
2021-10-04 08:00
3098
Colorectal cancer diagnoses dropped over 40% during COVID-19 pandemic, new study shows
VIENNA, Oct. 4, 2021 /PRNewswire/ -- The number of colorectal cancer (CRC) cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic, new research presented today at UEG Week Virtual 2021 has shown. The research, which was conducted across multiple hospitals in Spain, compa...
2021-10-04 06:00
1799
In Lead-up to Breast Cancer Awareness Month, New Hologic Global Women's Health Index Finds Globally Most Women Were Not Checked for Any Cancer in Past Year
Worldwide, 88% of women said in 2020 that they had not been tested for any type of cancer in the past 12 months. Most women believe checkups help improve health, but 40% haven't talked to a healthcare professional in the past 12 months. WASHINGTON, Oct. 2, 2021 /PRNewswire/ -- In the lead-up to ...
2021-10-02 12:18
3207
World's Leading Neuroscientists Unveil Research on COVID-19's Impact on the Brain, Understanding Migraine Pathophysiology, Solving the Mystery of Sleep, Biomarkers in Traumatic Brain Injury and More at 25th Biennial World Congress of Neurology from October 3-7
LONDON, Oct. 2, 2021 /PRNewswire/ -- The impact COVID-19 has on the brain, understanding migraine pathophysiology, solving the mystery of sleep by "Lighting Up the Brain," blood biomarkers for traumatic brain injury and more groundbreaking research will be unveiled by the world's leading neurosci...
2021-10-02 12:10
4416
CStone presents ARROW study data for GAVRETO® (pralsetinib) in Chinese patients with RET-mutant medullary thyroid cancer (MTC) for the first time in a late breaking oral abstract session at the 90th Annual Meeting of the American Thyroid Association 2021
* Primary efficacy results showed GAVRETO had robust and durable anti-tumor activity in the Chinese patients with advanced or metastatic RET-mutant medullary thyroid cancer (MTC), with a confirmed objective response rate (ORR) of 73.1%. And the 9-month duration of response (DOR) rate was 100% ...
2021-10-02 08:30
8881
Medidata Veterans Rama Kondru and Sastry Chilukuri Named co-CEOs
SINGAPORE and SYDNEY, Oct. 1, 2021 /PRNewswire/ -- Medidata, a Dassault
Systèmes company, recently namedRama Kondru
2021-10-01 09:00
2673
Fullerton Health Focuses on ASEAN in its Growth Strategy
SINGAPORE, Sept. 30, 2021 /PRNewswire/ -- Fullerton Health Corporation (FHC), Asia Pacific's leading vertically integrated healthcare platform has set its sights on growth inSoutheast Asia (ASEAN). ASEAN is the world's third most populous economy. By 2030, population will reach 723 million and th...
2021-09-30 22:25
2887
NCCN Publishes New Guide to Improving Knowledge and Quality of Life for Small Cell Lung Cancer Patients
New patient and caregiver resource from the National Comprehensive Cancer Network provides free expert consensus information on improving outcomes for people with an aggressive type of lung cancer. PLYMOUTH MEETING, Pa., Sept. 30, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® ...
2021-09-30 22:17
2031
CBMG Holdings Completes $120 Million in Series A Funding, Accelerating Development of CAR-T Therapy Pipelines and R&D for Innovative Solid Tumor Therapies
HONG KONG, Sept. 30, 2021 /PRNewswire/ -- CBMG Holdings (or the "Company"), a Cayman Island biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer and degenerative diseases, today announced the closing of a $120 million Series A investment, led by As...
2021-09-30 22:06
2782
Broncus Completed the First-in-man Clinical Trial of Its Targeted Lung Denervation Radiofrequency Ablation System
HONG KONG, Sept. 30, 2021 /PRNewswire/ -- Broncus Holding Corporation ("Broncus" or the "Company") is pleased to announce that it has completed the first-in-man clinical trial of its Targeted Lung Denervation (TLD) radiofrequency ablation system, which is expected to benefit patients with chroni...
2021-09-30 19:40
1978
Honda Prize 2021 Awarded to French Neurosurgeon and Physicist Dr. Alim Louis Benabid
TOKYO, Sept. 30, 2021 /PRNewswire/ -- The Honda Foundation, the public interest incorporated foundation established bySoichiro Honda and his younger brother Benjiro and currently led by PresidentHiroto Ishida, is pleased to announce that the Honda Prize 2021 will be awarded to Dr.Alim Louis Benab...
2021-09-30 16:00
1421
Zantrene® kills melanoma cancer cells that overproduce FTO
* Zantrene® at low concentrations kills high FTO producing melanoma cancer cells * Sensitivity to Zantrene® correlates with FTO levels, where high FTO producing cells show up to 60x greater sensitivity than low FTO producing cells * Results are highly supportive of future clinical trials in ...
2021-09-30 11:58
9902
Innovent Announces the First Patient Dosed in the Phase I/II Study of IBI351 (KRAS G12C inhibitor) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, Sept. 30, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2021-09-30 08:00
2819
Nanoform receives funding to solve challenges for global health
HELSINKI, Sept. 29, 2021 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be funded by the Bill & Melinda Gates Foundation to assess the added value Nanoform's award-winning CESS® nanoparticle engineering technology can d...
2021-09-29 21:15
1698
New Accedian Research Finds 76% of Manufacturers Plan to Use Private 5G by 2024
MONTREAL, Canada, Sept. 29, 2021 /PRNewswire/ -- Accedian, a leader in performance analytics, cybersecurity threat detection and end user experience solutions, today released new analyst research on the future of 5G in manufacturing. Conducted in partnership with Analysys Mason, a leading manage...
2021-09-29 21:07
1737
Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement
TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company "Wuhan Rhecogen Biotechnology Co., ...
2021-09-29 19:37
2314
Everest Medicines Initiates Submission of New Drug Application in Hong Kong for XeravaTM for the Treatment of Complicated Intra-abdominal Infections
SHANGHAI, Sept. 29, 2021 /PRNewswire/ -- Everest Medicines
2021-09-29 17:44
2539
Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting
Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology compa...
2021-09-29 15:00
1417
Zhaoke Ophthalmology's IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE
* Targets broadest patient group – three to 17 years old * Two concurrent clinical trials, one leveraging global study to accelerate time to market * Phase III clinical trials testing two different doses to tailor for individual patients HONG KONG, Sept. 29, 2021 /PRNewswire/ -- Zhaoke Opht...
2021-09-29 12:17
4115
ClearMask introduces world's first CE-marked, fully transparent surgical mask
Fully transparent, anti-fog masks available in the European Union to provide clear communication and safety for healthcare providers and essential workers BALTIMORE, Sept. 29, 2021 /PRNewswire/ -- ClearMask LLC, a privately held American medical supply company, announced today that its ClearMask™...
2021-09-29 09:00
1953
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 292 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 290 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8835
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
8784
Animated Life in Yunnan
2024-04-18 14:00
7822
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7732
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3894